Pay in 4 interest-free payments of $6.04 Learn more
Ships within 48 hours · Estimated delivery Oct 14 - Oct 19
An evolving body of evidence shows that weight reduction improves health outcomes beyond its effect on intermediary CVD risk factors
After 64 weeks, people taking semaglutide had lost an average of 13.6% of their body weight, compared to just 2.2% in the placebo group
PlexusDx's personalized approach through the optional Precision Peptide Genetic Test may reveal individual predispositions to GLP-1 pathway sensitivity, helping you anticipate tolerance patterns
It may support healthy skin by reducing inflammation and oxidative stress and also improve energy metabolism
A comprehensive consultation can help determine which combination of treatments is most appropriate for your body and goals
Whoopi Goldberg Reveals She Used Weight Loss Medication Mounjaro After Hitting 300 Lbs.: Thats a Lot of Me
US$ 22.38
US$ 22.48
US$ 28.09
US$ 24.55
